• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用随机效应选择模型对生活质量和生存率进行联合分析。

A joint analysis of quality of life and survival using a random effect selection model.

作者信息

Ribaudo H J, Thompson S G, Allen-Mersh T G

机构信息

Department of Biostatistics, Harvard School of Public Health, Boston, MA 02115, USA.

出版信息

Stat Med. 2000 Dec 15;19(23):3237-50. doi: 10.1002/1097-0258(20001215)19:23<3237::aid-sim624>3.0.co;2-q.

DOI:10.1002/1097-0258(20001215)19:23<3237::aid-sim624>3.0.co;2-q
PMID:11113957
Abstract

In studies of patients with advanced disease, longitudinal quality of life data may be truncated as a result of early death. Since survival and quality of life are likely to be related, modelling of the quality of life response needs to account for these different survival patterns. Here we discuss the application of a random effect selection model, in the form of a trivariate Normal model for the joint analysis of quality of life response (intercept and slope) and log survival time. Under certain assumptions this can give an unbiased description of the quality of life responses and valid inferences comparing treatment strategies in a clinical trial. It also indicates how quality of life and survival are related, by estimating the expected quality of life responses conditional on different survival times. Model parameters can be estimated using a restricted iterative generalized least-squares (RIGLS) procedure within standard software, extended to handle censoring of survival outcome using an EM algorithm. The model is applied to a physical quality of life score and survival data from a trial of treatment for patients with colorectal hepatic metastases. Survival differed between the treatment groups, and quality of life repsonse tended to be worse, both in initial level and change over time, for those patients who died earlier. The parameter estimates obtained agreed well with those from analysing the extended trial data set with complete survival information. Residual diagnostics used to check the necessary underlying assumptions of the model are exemplified. We conclude that such models can give an informative description of longitudinal responses when these are truncated by differential survival patterns.

摘要

在对晚期疾病患者的研究中,由于早期死亡,纵向生活质量数据可能会被截断。由于生存和生活质量可能相关,生活质量反应的建模需要考虑这些不同的生存模式。在此,我们讨论一种随机效应选择模型的应用,该模型采用三变量正态模型的形式,用于联合分析生活质量反应(截距和斜率)和对数生存时间。在某些假设下,这可以对生活质量反应给出无偏描述,并在临床试验中对比较治疗策略进行有效推断。它还通过估计不同生存时间条件下的预期生活质量反应,表明生活质量与生存之间的关系。模型参数可以使用标准软件中的受限迭代广义最小二乘法(RIGLS)程序进行估计,并通过期望最大化(EM)算法进行扩展以处理生存结局的删失情况。该模型应用于一项针对结直肠癌肝转移患者治疗试验的身体生活质量评分和生存数据。治疗组之间的生存情况不同,对于那些较早死亡的患者,生活质量反应在初始水平和随时间变化方面往往更差。获得的参数估计值与分析具有完整生存信息的扩展试验数据集所得结果吻合良好。文中举例说明了用于检验模型必要基本假设的残差诊断方法。我们得出结论,当纵向反应因不同的生存模式而被截断时,此类模型可以对其给出有价值的描述。

相似文献

1
A joint analysis of quality of life and survival using a random effect selection model.使用随机效应选择模型对生活质量和生存率进行联合分析。
Stat Med. 2000 Dec 15;19(23):3237-50. doi: 10.1002/1097-0258(20001215)19:23<3237::aid-sim624>3.0.co;2-q.
2
Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.持续肝动脉输注氟尿苷治疗结直肠癌肝转移的生活质量与生存率
Lancet. 1994 Nov 5;344(8932):1255-60. doi: 10.1016/s0140-6736(94)90750-1.
3
Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver.用于治疗肝转移结直肠癌的肝动脉化疗
Oncology. 2000 Aug;59(2):89-97. doi: 10.1159/000012142.
4
Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.基础研究推动了不可切除孤立性结直肠癌肝转移化疗的发展,形成了一种采用米托蒽醌、5-氟尿嘧啶+亚叶酸和丝裂霉素C的肝动脉灌注方案。
Gan To Kagaku Ryoho. 1999 Feb;26(3):269-81.
5
Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update.肝动脉注射氟尿苷和亚叶酸治疗不可切除的结直肠癌肝转移。新的剂量方案及生存情况更新
Cancer. 1994 Feb 15;73(4):1134-42. doi: 10.1002/1097-0142(19940215)73:4<1134::aid-cncr2820730403>3.0.co;2-v.
6
Hepatic artery infusion for liver metastases from colorectal cancer.肝动脉灌注治疗结直肠癌肝转移
Lancet. 2003 Feb 1;361(9355):358-9. doi: 10.1016/S0140-6736(03)12439-7.
7
Regional chemotherapy of colorectal cancer.结直肠癌的区域化疗
Eur J Cancer. 1995 Jul-Aug;31A(7-8):1271-6. doi: 10.1016/0959-8049(95)00162-c.
8
Re: Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer.关于:重新评估肝动脉灌注在治疗不可切除的结直肠癌肝转移中的应用。
J Natl Cancer Inst. 1996 Jun 19;88(12):838-9. doi: 10.1093/jnci/88.12.838-a.
9
Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial.动脉内氟尿苷与全身氟尿嘧啶治疗结直肠癌肝转移的随机试验
Arch Surg. 1990 Aug;125(8):1022-7. doi: 10.1001/archsurg.1990.01410200086013.
10
Prevention of extrahepatic disease during intraarterial floxuridine of colorectal liver metastases by simultaneous systemic 5-fluorouracil treatment? A prospective multicenter study.
Gan To Kagaku Ryoho. 1989 Dec;16(12):3662-71.

引用本文的文献

1
A structured methodology review showed analyses of functional outcomes are frequently limited to "survivors only" in trials enrolling patients at high risk of death.一项结构化方法学综述显示,在招募高死亡风险患者的试验中,功能结局分析通常仅限于“仅幸存者”。
J Clin Epidemiol. 2021 Sep;137:126-132. doi: 10.1016/j.jclinepi.2021.03.027. Epub 2021 Apr 7.
2
Estimating inverse-probability weights for longitudinal data with dropout or truncation: The xtrccipw command.估计存在失访或删失的纵向数据的逆概率权重:xtrccipw命令
Stata J. 2017;17(2):253-278.
3
Accommodating informative dropout and death: a joint modelling approach for longitudinal and semi-competing risks data.
处理信息性失访和死亡:一种用于纵向数据和半竞争风险数据的联合建模方法。
J R Stat Soc Ser C Appl Stat. 2018 Jan;67(1):145-163. doi: 10.1111/rssc.12210. Epub 2017 Jan 30.
4
Joint Analysis of Survival Time and Longitudinal Categorical Outcomes.生存时间与纵向分类结局的联合分析
Stat Biosci. 2015 May;7(1):19-47. doi: 10.1007/s12561-013-9091-z.
5
Health-related quality of life and risk of colorectal cancer recurrence and All-cause death among advanced stages of colorectal cancer 1-year after diagnosis.结直肠癌晚期诊断后1年与健康相关的生活质量、复发风险及全因死亡情况
BMC Cancer. 2014 May 17;14:337. doi: 10.1186/1471-2407-14-337.
6
Longitudinal Data with Follow-up Truncated by Death: Match the Analysis Method to Research Aims.随访因死亡而截断的纵向数据:使分析方法与研究目的相匹配。
Stat Sci. 2009;24(2):211. doi: 10.1214/09-STS293.
7
The influence of age on changes in health-related quality of life over three years in a cohort undergoing hemodialysis.年龄对一组接受血液透析患者三年内健康相关生活质量变化的影响。
J Am Geriatr Soc. 2008 Sep;56(9):1608-17. doi: 10.1111/j.1532-5415.2008.01849.x. Epub 2008 Aug 21.
8
Weighted estimating equations for longitudinal studies with death and non-monotone missing time-dependent covariates and outcomes.针对具有死亡以及非单调缺失的随时间变化协变量和结局的纵向研究的加权估计方程。
Stat Med. 2008 Mar 30;27(7):1008-25. doi: 10.1002/sim.2964.
9
Joint modeling of event time and nonignorable missing longitudinal data.事件时间与不可忽略的缺失纵向数据的联合建模
Lifetime Data Anal. 2002 Jun;8(2):99-115. doi: 10.1023/a:1014871806118.